Vimarsana
Biggest News Aggregation in the World

Page 3 - Crossover Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crossover Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crossover Management Today - Breaking & Trending Today

Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Up 6.2% in March - Vimarsana News

Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Up 6.2% in March

Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 9,630,000 shares, an increase of 6.2% from the February 29th total of 9,070,000 shares. Based on an average trading volume of 2,160,000 shares, […]

Aerovate Therapeutics (NASDAQ:AVTE) Reaches New 12-Month High at $28.39 - Vimarsana News

Aerovate Therapeutics (NASDAQ:AVTE) Reaches New 12-Month High at $28.39

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $28.39 and last traded at $27.85, with a volume of 25873 shares trading hands. The stock had previously closed at $25.78. Analysts Set New Price Targets AVTE has been the subject of several […]

Source: wkrb13.com
Cogent Biosciences' (COGT) "Neutral" Rating Reiterated at Robert W. Baird - Vimarsana News

Cogent Biosciences' (COGT) "Neutral" Rating Reiterated at Robert W. Baird

Robert W. Baird reiterated their neutral rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. They currently have a $8.00 target price on the technology company’s stock, down from their prior target price of $14.00. Other analysts also recently issued reports about […]

Source: wkrb13.com
Needham & Company LLC Reaffirms Buy Rating for Cogent Biosciences (NASDAQ:COGT) - Vimarsana News

Needham & Company LLC Reaffirms Buy Rating for Cogent Biosciences (NASDAQ:COGT)

Needham & Company LLC reissued their buy rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research note published on Monday, Benzinga reports. Needham & Company LLC currently has a $18.00 price objective on the technology company’s stock. Several other research firms also recently commented on COGT. JPMorgan Chase & Co. began […]

Cogent Biosciences (NASDAQ:COGT) Shares Pass Below 50-Day Moving Average of $5.87 - Vimarsana News

Cogent Biosciences (NASDAQ:COGT) Shares Pass Below 50-Day Moving Average of $5.87

Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares traded. Analysts Set New Price Targets […]